Albireo Pharma, Inc.(NasdaqCM:ALBO) dropped from S&P Global BMI Index
Albireo Pharma, Inc.
Equities
ALBO
US01345P1066
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+14.84% | 121B | |
+18.31% | 112B | |
+4.48% | 22.57B | |
-18.26% | 20.82B | |
-16.75% | 16.19B | |
-42.36% | 16.17B | |
-14.23% | 16.3B | |
-0.68% | 13.17B | |
+21.87% | 11.11B |